Dr Vinodh Kumar Selvaraj speaks to ecancer about his new article published in ecancermedicalscience.

Dr Selvaraj gives an overview of the article, which explores the application and role of nanoparticles in cancer immunotherapy and radiotherapy.

He also discusses the main advantages and limitations associated with this type technology, which include uncertainties regarding immune response and toxicity.

Dr Selvaraj describes the future developments in this area, where next-generation nanoparticles could be developed to enhance the active targeting of tumour cells, and the compatibility with other anti-cancer therapies.